The normal role of Activated Protein C in maintaining homeostasis and its relevance to critical illness

被引:46
作者
Esmon, CT [1 ]
机构
[1] Oklahoma Med Res Fdn, Howard Hughes Med Inst, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA
来源
CRITICAL CARE | 2001年 / 5卷 / Suppl 2期
关键词
Activated Protein C; coagulation; endothelial cell Protein C receptor (EPCR); inflammation; thrombomodulin;
D O I
10.1186/cc1333
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Thrombin is a multifunctional protein, with procoagulant, inflammatory and anticoagulant effects. Binding of thrombin to thrombomodulin results in activation of Protein C and initiation of the Activated Protein C anticoagulant pathway, a process that is augmented by the endothelial cell Protein C receptor (EPCR). Activated Protein C has demonstrated antithrombotic, anti-inflammatory, and profibrinolytic properties. Its antithrombotic activity is particularly important in the microcirculation, and Protein C deficiency is associated with microvascular thrombosis. Activated Protein C has also been shown to modulate inflammation. When the level of thrombomodulin or Protein C is reduced in sepsis there is a vicious cycle of coagulation and inflammation, with potentially lethal consequences. In vitro studies and animal models have shown that Activated Protein C blunts the inflammatory and coagulant response to sepsis through a variety of mechanisms.
引用
收藏
页码:S7 / S12
页数:6
相关论文
共 23 条
  • [1] TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex
    Bajzar, L
    Morser, J
    Nesheim, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (28) : 16603 - 16608
  • [2] PURIFICATION AND CHARACTERIZATION OF TAFI, A THROMBIN-ACTIVABLE FIBRINOLYSIS INHIBITOR
    BAJZAR, L
    MANUEL, R
    NESHEIM, ME
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (24) : 14477 - 14484
  • [3] BUSCH C, 1982, LAB INVEST, V47, P498
  • [4] Esmon CT, 1999, HANDB EXP PHARM, V132, P447
  • [5] Inflammation: The protein C pathway
    Esmon, CT
    Fukudome, K
    Mather, T
    Bode, W
    Esmon, NL
    Regan, LM
    StearnsKurosawa, DJ
    Kurosawa, S
    [J]. FIBRINOLYSIS & PROTEOLYSIS, 1997, 11 : 143 - 148
  • [6] Esmon CT, 1998, IMMUNOLOGIST, V6, P84
  • [7] Esmon CT, 2000, THROMB HAEMOSTASIS, V83, P639
  • [8] ESMON CT, 1993, ANNU REV CELL BIOL, V9, P1
  • [9] ESMON CT, 2001, IN PRESS ACTIVATED P
  • [10] Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex
    Fuentes-Prior, P
    Iwanaga, Y
    Huber, R
    Pagila, R
    Rumennik, G
    Seto, M
    Morser, J
    Light, DR
    Bode, W
    [J]. NATURE, 2000, 404 (6777) : 518 - 525